The global Human Papillomavirus Treatment Market witnessed substantial growth in 2021 and is projected to maintain a rapid revenue compound annual growth rate (CAGR) throughout the forecast period. HPV is the most common viral infection of the reproductive system, with the majority of sexually active individuals experiencing the disease at some point in their lives. Immunosuppression, a significant risk factor for chronic HPV infections and associated illnesses, has increased during the COVID-19 pandemic, driving market growth.

https://www.reportsanddata.com..../report-detail/human